Possible treatment found for 'chemobrain'

Patients who take medication for cancer often find themselves with a new problem when their treatment ends.

It's called "chemobrain," a common consequence of chemotherapy that causes memory problems, confusion and difficulty in concentrating.

Symptoms of chemobrain can also include lack of focus, inability to organize daily activities, mental confusion, memory loss and decreased mental clarity.

It's estimated that chemobrain occurs in as many as 99 percent of breast and ovarian cancer patients receiving chemotherapy or radiation treatments. Sixty-one percent of these patients continue to experience fatigue and memory problems long after their cancer treatment has stopped.

Now, researchers led by the University of Cincinnati's (UC) Elyse Lower, MD, report a possible new treatment for the problem using the drug dexmethyphenidate (d-MPH).

Dr. Lower, professor of hematology/oncology at UC College of Medicine, recently described the encouraging results of a 14-month, multi-center, Phase 2 study of d-MPH to the annual meeting of the American Society of Clinical Oncology.

The 154 cancer survivors at 21 medical centers showed significant reduction in fatigue and improvement in memory when treated with dosages of 10 mg to 50 mg of d-MPH per day, Dr. Lower said, when compared with a control group receiving a placebo.

All the patients, who had a median age of 53 years, had completed at least four cycles of chemotherapy at least two months before the study began. Ninety percent of them were female (76 percent with breast cancer and 14 percent with ovarian cancer), 79 percent were white and 9 percent were African-American.

"The study showed that up to 50 mg a day of d-MPH is safe and effective for relieving chemobrain in adult cancer patients," said Dr. Lower, "and it should be considered as a treatment."

One of the study participants, Marilyn Metz, had undergone radiation and chemotherapy in 2001 to t

Contact: Sheryl Hilton
University of Cincinnati

Page: 1 2

Related medicine news :

1. Possible new breast cancer gene
2. Possible predictors of relationship violence
3. Possible exposure to nerve agents and brain cancer deaths in Gulf War veterans
4. Spot on treatment for acne
5. New treatment boosts muscle function in myasthenia gravis
6. New treatment effective in counteracting cocaine-induced symptoms
7. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
8. Preventive treatments in elderly people needs rethinking
9. Osteoporosis screening and treatment may be cost-effective for selected older men
10. Quality of treatment guidelines
11. Green tea holds promise as new treatment for inflammatory skin diseases

Post Your Comments:

(Date:12/1/2015)... ... , ... With FCPX Overlay: Grit , users can apply a grit ... are truly endless, all with a click of a mouse. Each user has full ... depth of field and more, all within Final Cut Pro X. , With FCPX ...
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare ... 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes ... and propose exciting enhancements to the medical landscape. , The UCLH team won ...
(Date:11/30/2015)... ... 30, 2015 , ... Olympic Gold Medalists and Celebrity Moms ... across various categories through traditional and social media marketing campaigns and other branding ... Gold Medal Moms who can connect with today’s most important consumer: mothers. In ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
(Date:11/30/2015)... Los Angeles, California (PRWEB) , ... November 30, ... ... in all the programs of the19th Bi-National Convention of the Federation of Philippine ... Resort and Casino in Las Vegas, Nevada. , 1Heart Caregiver Services, as ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015  Roche ... wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide ... small molecule inhibitor of Vascular Adhesion Protein 1 (VAP-1), ... treatment of inflammatory disease. The VAP-1 inhibitor is currently ... --> Under the terms of the ...
(Date:11/30/2015)... LOUIS , Dec. 1, 2015 Express Scripts ... Imprimis Pharmaceuticals (NASDAQ: IMMY ) to drive access to ... for the treatment of toxoplasmosis that has been recently priced ... others with weakened immune systems. --> ... of pyrimethamine and leucovorin (a form of folic acid) for $1 ...
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... http://photos.prnewswire.com/prnh/20151124/290547 Foto: http://photos.prnewswire.com/prnh/20151124/290548 ... http://photos.prnewswire.com/prnh/20121014/HK92339LOGO-d --> ...
Breaking Medicine Technology:
Cached News: